Characterization of cytochrome P450 enzymes involved in drug oxidations in mouse intestinal microsomes

References

• BRIAN, W. R., SRIVASTAVA, P. K., UMBENHAUER, D. R., LLOYD, R. S. and GUENGERICH, F. P., 1989, Expression of a human liver cytochrome P450 protein with tolbutamide hydroxylase activity in Saccharomyces cerevisiae. Biochemistry, 28, 4993–4999.
   PubMed Web of Science ®Google Scholar
• GUENGERICH, F. P., 1991, Reaction and significance of cytochrome P-450 enzymes. Journal of Biological Chemistry, 266, 10019–10022.
   PubMed Web of Science ®Google Scholar
• GUENGERICH, F. P., 1994, Analysis and characterization of enzymes. In A. W. Hayes (ed.), Principles and Methods of Toxicology (New York: Raven), pp. 1259–1313.
   Google Scholar
• GUENGERICH, F. P., 1995, Human cytochrome P450 enzymes. In P. R. Oritiz de Montellano (ed.), Cytochronw P450 (New York: Plenum), pp. 473–535.
   Google Scholar
• GUENGERICH, F. P., HOSEA, N. A. and MARTIN, M. V., 1998, Purification of cytochromes P450: products of bacterial recombinant expression systems. In I. R. Phillips and E. A. Shephard (eds), Cytochronw P450 Protocols (Totowa: Humana), pp. 77–83.
   Google Scholar
• IATSIMIRSKAIA, E., TULEBAEV, S., STOROZHUK, E., UTKIN, I., SMITH, D., GERBER, N. and KOUDRIAKOVA, T., 1997, Metabolism of rifabutin in human enterocyte and liver microsomes: kinetic parameters, identification of enzyme systems, and drug interactions with macrolides and antifungal agents. Clinical Pharmacology and Therapeutics, 61, 554–562.
   PubMed Web of Science ®Google Scholar
• KASHFI, K., MCDOUGALL, C. J. and DANNENBERG, A. J., 1995, Comparative effects of omeprazole OR xenobiotic metabolizing enzymes in the rat and human. Clinical Pharmacology and Therapeutics, 58, 625–630.
   PubMed Web of Science ®Google Scholar
• KOMURA, H., SAGAMI, M. and YOSHIDA, N. H., 1998, Establishment for evaluation system of small intestinal metabolism. Abstract for the 5th annual meeting of the HAB Discussion Group, 5, 1.
   Google Scholar
• KRISHNA, D. R. and KLOTZ, U., 1994, Extrahepatic metabolism of drugs in humans. Clinical Pharmacokinetics, 26, 144–160.
   PubMed Web of Science ®Google Scholar
• KRONBACH, T., MATHYS, D., GUT, J., CATIN, T. and MEYER, U. A., 1987, High-performance liquid chromatographic assays for bufuralol 1'-hydroxylase, debrisoquine 4-hydroxylase, and dextro-methorphan 0-demethylase in microsomes and purified cytochrome P450 isozymes of human liver. Analytical Biochemistry, 162, 24–32.
   PubMed Web of Science ®Google Scholar
• KRONBACH, T., MATHYS, D., UMENO, M., GONZALEZ, F. J. and MEYER, U. A., 1989, Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4. Molecular Pharmacology, 36, 89–96.
   PubMed Web of Science ®Google Scholar
• LAEMMLI, U. K., 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680–685.
   PubMed Web of Science ®Google Scholar
• LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent Journal of Biological Chemistry, 193, 265–275.
   Google Scholar
• PAINE, M. F., KHALIGHI, M., FISHER, J. M., SHEN, D. D., KUNZE, K. L., MARSH, C. L., PERKINS, J. D. and THUMMEL, K. E., 1997, Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. Journal of Pharmacology and Experimental Therapeutics, 283, 1552–1562.
   PubMed Web of Science ®Google Scholar
• PAINE, M. F., SHEN, D. D., KUNZE, K. L., PERKINS, J. D., MARSH, C. L., McVicAR, J. P., BARR, D. M., GILLIES, B. S. and THUMMEL, K. E., 1996, First-pass metabolism of midazolam by the human intestine. Clinical Pharmacology and Therapeutics, 60, 14–24.
   PubMed Web of Science ®Google Scholar
• PEARCE, R. E., MCINTYRE, C. J., MADAN, A., SANZGIRI, U., DRAPER, A. J., BULLOCK, P. L., COOK, D. C., BURTON, L. A., LATHAM, J., NEVINS, C. and PARKINSON, A., 1996, Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity. Archives of Biochemistry and Biophysics, 331, 145–169.
   PubMed Web of Science ®Google Scholar
• PETER, R., BoCKER, R., BEAUNE, P. H., IWASAKI, M., GUENGERICH, F. P. and YANG, C. S., 1990, Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P450HE1. Chemical Research in Toxicology, 3, 566–573.
   PubMed Web of Science ®Google Scholar
• PRUEKSARITANONT, T., GORHAM, L. M., HOCHMAN, J. H., TRAN, L. O. and VYAS, K. P., 1996, Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells. Drug Metabolism and Disposition, 24, 634–642.
   PubMed Web of Science ®Google Scholar
• ROSENBERG, D. W. and MANKOWSKI, D. C., 1994, Induction of cyp2e-1 protein in mouse colon. Carcinogenesis, 15, 73–78.
   PubMed Web of Science ®Google Scholar
• SAKUMA, T., TAKAI, M., ENDO, Y., KUROIWA, M., OHARA, A., JARUKAMJORN, K., HONMA, R. and NEMOTO, N., 2000, A novel female-specific member of the CYP3A gene subfamily in the mouse liver. Archives of Biochemistry and Biophysics, 377, 153–162.
   PubMed Web of Science ®Google Scholar
• SHIMADA, T., YAMAZAKI, H., MIMURA, M., INUI, Y. and GUENGERICH, F. P., 1994, Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. Journal of Pharmacology and Experimental Therapeutics, 270, 414–423.
   PubMed Web of Science ®Google Scholar
• Shimizu, R., HANANO, M. and SATO, T., 1998, Preparation and storage of human intestinal microsomes. Xenobiotic Metabolism and Disposition, 13, S254.
   Google Scholar
• WATKINS, P. B., WRIGHTON, S. A., SCHUETZ, E. G., MOLOWA, D. T. and GUZELIAN, P. S., 1987, Identification of glucocorticoid-inducible cytochromes P450 in the intestinal mucosa of rats and man. Journal of Clinical Investigation, 80, 1029–1036.
   PubMed Web of Science ®Google Scholar
• YAMAZAKI, H., Guo, Z., PERSMARK, M., MIMURA, M., INOUE, K., GUENGERICH, F. P. and SHIMADA, T., 1994, Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes. Molecular Pharmacology, 46, 568–577.
   PubMed Web of Science ®Google Scholar
• YAMAZAKI, H., INouE, K., TURVY, C. G., GUENGERICH, F. P. and SHIMADA, T., 1997, Effects of freezing, thawing, and storage of human liver samples on the microsomal contents and activities of cytochrome P450 enzymes. Drug Metabolism and Disposition, 25, 168–174.
   PubMed Web of Science ®Google Scholar
• YAMAZAKI, H. and SHIMADA, T., 1997, Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes. Archives of Biochemistry and Biophysics, 346, 161–169.
   PubMed Web of Science ®Google Scholar
• YANAGIMOTO, T., troll, S., SAWADA, M. and KAMATAKI, T., 1997, Mouse cytochrome P450 (Cyp3a11): predominant expression in liver and capacity to activate afiatoxin B1. Archives of Biochemistry and Biophysics, 340, 215–218.
   PubMed Web of Science ®Google Scholar
• ZHANG, Q. Y., WIKOFF, J., DUNBAR, D. and KAMINSKY, L., 1996, Characterization of rat small intestinal cytochrome P450 composition and inducibility. Drug Metabolism and Disposition, 24, 322–328.
   PubMed Web of Science ®Google Scholar